CytoLyt fixation impedes insulinoma-associated protein 1 (INSM1) immunoreactivity compared to formalin fixation
Journal of the American Society of Cytopathology · 2024
DOI: 10.1016/j.jasc.2024.02.002 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of the American Society of Cytopathology, 2024. Verfasst von Michelle Garlin-Politis und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York Presbyterian Hospital, New York, New York. Electronic a…. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Formaldehyde, Immunohistochemistry, Repressor Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 15 Literaturangaben. Gefördert von: Columbia University Irving Medical Center.
Abstract (Originalsprache)
INTRODUCTION: Insulinoma-associated protein 1 (INSM1) is an immunohistochemical marker commonly used to confirm cytomorphological concordant neuroendocrine tumors/carcinomas (NETs/NECs), demonstrating high utility in small samples. Previous reports have suggested comparable INSM1 staining in CytoLyt-fixed cell blocks and formalin-fixed surgical pathology specimens. This study aimed to assess INSM1 immunoreactivity using both fixation methods and investigate potential factors contributing to its variable expression. MATERIALS AND METHODS: A retrospective query was performed (03/31/21-05/31/22) for NET/NEC cases that had both formalin- and CytoLyt-fixed cell blocks. We collected clinical data and reporting of immunostains for each case. INSM1 staining was evaluated in both fixation methods, and reported as positive, negative, or equivocal. Equivocal INSM1 staining was further scored as a percentage of 1%-100% and intensity of weak (faint staining), moderate (darker staining), and strong (dense staining). RESULTS: Our search identified 20 cases from diverse body sites, including mediastinal lymph nodes (40%), pancreas (35%), lung (20%), and porta hepatis lymph nodes (5%). All cases exhibited a widespread positivity (over 90%) in formalin-fixed cell blocks. In contrast, CytoLyt fixed cells showed a negative stain in 65% of cases and 30% exhibited an equivocal positivity. CONCLUSIONS: While INSM1 is previously reported as a sensitive (75%-100%) and specific (82.7%-100%) marker for NET/NECs, our study found a reduced immunohistochemical staining in CytoLyt-fixed cell blocks. Consequently, false negative INSM1 immunohistochemical results in CytoLyt-fixed cell block material may pose a pitfall in the diagnosis of NET/NEC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York Presbyterian Hospital, New York, New York. Electronic address: mg4384@cumc.columbia.edu.
- Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York Presbyterian Hospital, New York, New York; Department of Pathology and Laboratory Medicine, University of California Davis He…
- Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York Presbyterian Hospital, New York, New York.
Förderung
- Columbia University Irving Medical Center
Zitieren
APA
Garlin-Politis, M., Upadhyay Baskota, S., Picon, S., Collins, N., Virk, R. K., Cimic, A., Yousefi, E., & Gonzalez, A. (2024). CytoLyt fixation impedes insulinoma-associated protein 1 (INSM1) immunoreactivity compared to formalin fixation. Journal of the American Society of Cytopathology. https://doi.org/10.1016/j.jasc.2024.02.002
Vancouver
Garlin-Politis M, Upadhyay Baskota S, Picon S, Collins N, Virk RK, Cimic A, et al. CytoLyt fixation impedes insulinoma-associated protein 1 (INSM1) immunoreactivity compared to formalin fixation. Journal of the American Society of Cytopathology. 2024. doi:10.1016/j.jasc.2024.02.002
BibTeX
@article{GarlinPolitis2024,
author = {Garlin-Politis, Michelle and Upadhyay Baskota, Swikrity and Picon, Sarah and Collins, Nikosa and Virk, Renu Kaur and Cimic, Adela and Yousefi, Elham and Gonzalez, Abel},
title = {CytoLyt fixation impedes insulinoma-associated protein 1 (INSM1) immunoreactivity compared to formalin fixation},
journal = {Journal of the American Society of Cytopathology},
year = {2024},
doi = {10.1016/j.jasc.2024.02.002}
}
EUVIMED